Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
about
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In VivoAntibiotics and pharmacogenomics.The treatment of Legionnaires' disease.Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy.Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumoniaRetrospective analysis of azithromycin versus fluoroquinolones for the treatment of legionella pneumonia.In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice.Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep.
P2860
Q27660498-4F393B05-92A5-47E4-9E6D-7E74D8511D63Q33188297-7C9F19CC-3E57-45EF-9E30-A5008396250AQ33686303-E001368D-706D-40B1-9203-FCA926A8D8FFQ33978028-AFB80F11-3C1A-422A-979F-1144FBFE5ED5Q34596388-29A77D56-F961-469D-8359-CD369F8C68CFQ35122254-2F2EFAEE-0FBF-4E9F-83ED-D7D4BBFB4FA4Q39076724-44E846AE-B91A-4CBC-883F-3A8C8A157FE7Q39477931-025059DD-C462-4298-91E2-59A3B9105D14Q39478420-6343F29F-D12D-4EF2-968D-1EAE03BC6CE8Q39559639-10B253DA-69F8-48B5-82B1-2560FBBF859CQ39740470-79FEC152-8F00-4A05-940F-8EE86F3424C1Q45273493-18C0EE2D-B2BE-4046-91BE-5486AFDB167DQ46038541-FE475ECF-CC5E-45D8-B354-1DDD22BFF21EQ46737780-72BD4DDB-0B26-4E8D-A422-2E6E7CAAC050
P2860
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@ast
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@en
type
label
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@ast
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@en
prefLabel
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@ast
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@en
P2093
P2860
P356
P1476
Azithromycin pharmacokinetics ...... nd their alveolar macrophages.
@en
P2093
Edelstein MA
Edelstein PH
Stamler DA
P2860
P304
P356
10.1128/AAC.38.2.217
P407
P577
1994-02-01T00:00:00Z